MRNA

Moderna, Inc.

139.98 USD
-0.06 (-0.04%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Moderna, Inc. stock is up 5.5% since 30 days ago. The next earnings date is Aug 1, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 5 June’s closed higher than May. In the last 10 Unusual Options Trades, there were 7 CALLs, 3 PUTs. 50% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
14 Jun 15:46 16 Aug, 2024 140.00 CALL 20 596
14 Jun 16:16 21 Mar, 2025 95.00 CALL 5 0
14 Jun 16:20 18 Dec, 2026 140.00 CALL 5 11
14 Jun 16:33 21 Jun, 2024 140.00 PUT 80 1789
14 Jun 17:35 18 Oct, 2024 145.00 PUT 14 678
14 Jun 17:40 16 Aug, 2024 145.00 PUT 20 220
14 Jun 19:34 21 Jun, 2024 90.00 CALL 5 382
14 Jun 19:43 18 Oct, 2024 150.00 CALL 32 664
14 Jun 19:43 18 Oct, 2024 150.00 CALL 38 664
14 Jun 19:58 20 Sep, 2024 130.00 CALL 13 1487

About Moderna, Inc.

Moderna, Inc. develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases. The company has 44 development programs, which includes 26 in clinical trials across seven modalities.

  • RBC Capital
    Mon Jun 3, 13:37
    buy
    confirm
  • Needham
    Mon Jun 3, 05:33
    hold
    confirm